BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

531592

GENPHARMA

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

GENPHARMASEC LIMITED Share Price Update

As of the latest trading session, GENPHARMASEC LIMITED share price is currently at ₹ 2.04, which is down by ₹ -0.03 from its previous closing. Today, the stock has fluctuated between ₹ 2.00 and ₹ 2.14. Over the past year, GENPHARMASEC LIMITED has achieved a return of -5.88 %. In the last month alone, the return has been 9.47 %. Read More...

GENPHARMASEC LIMITED fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    112.95

  • P/E Ratio (TTM)

    41.60

  • Beta

    0.60

  • Book Value / share

    1.19

  • Return on equity

    0.11%

  • EPS (TTM)

    0.05

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    1.13

info icon alternate text

GENPHARMASEC LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 8.34
Operating Expense 7.53
Net Profit 1.13
Net Profit Margin (%) 13.54
Earnings Per Share (EPS) 0.02
EBITDA 1.90
Effective Tax Rate (%) 35.05
Particulars SEP 2024 (Values in Cr)
Revenue 5.77
Operating Expense 5.60
Net Profit 1.00
Net Profit Margin (%) 17.33
Earnings Per Share (EPS) 0.02
EBITDA 1.11
Effective Tax Rate (%) 2.91
Particulars JUN 2024 (Values in Cr)
Revenue 5.30
Operating Expense 5.15
Net Profit 0.59
Net Profit Margin (%) 11.13
Earnings Per Share (EPS) 0.01
EBITDA 0.80
Effective Tax Rate (%) 19.17
Particulars MAR 2024 (Values in Cr)
Revenue 10.20
Operating Expense 10.18
Net Profit -0.05
Net Profit Margin (%) -0.49
Earnings Per Share (EPS) 0.00
EBITDA 0.47
Effective Tax Rate (%) 115.15
Particulars DEC 2023 (Values in Cr)
Revenue 6.38
Operating Expense 6.49
Net Profit 0.06
Net Profit Margin (%) 0.94
Earnings Per Share (EPS) 0.00
EBITDA 0.15
Effective Tax Rate (%) -100.00
Particulars MAR 2024 (Values in Cr)
Revenue 30.41
Operating Expense 30.65
Net Profit 0.05
Net Profit Margin (%) 0.16
Earnings Per Share (EPS) -0.01
EBITDA 0.88
Effective Tax Rate (%) 89.36
Particulars MAR 2023 (Values in Cr)
Revenue 25.52
Operating Expense 25.34
Net Profit 1.12
Net Profit Margin (%) 4.38
Earnings Per Share (EPS) 0.04
EBITDA 0.36
Effective Tax Rate (%) -299.99
Particulars MAR 2022 (Values in Cr)
Revenue 27.32
Operating Expense 27.86
Net Profit -0.21
Net Profit Margin (%) -0.76
Earnings Per Share (EPS) -0.01
EBITDA -0.43
Effective Tax Rate (%) 52.27
Particulars MAR 2021 (Values in Cr)
Revenue 21.31
Operating Expense 20.13
Net Profit 1.26
Net Profit Margin (%) 5.91
Earnings Per Share (EPS) 0.05
EBITDA 1.52
Effective Tax Rate (%) 16.55
Particulars MAR 2020 (Values in Cr)
Revenue 16.50
Operating Expense 15.86
Net Profit 1.01
Net Profit Margin (%) 6.12
Earnings Per Share (EPS) 0.05
EBITDA 1.21
Effective Tax Rate (%) 16.52
Particulars MAR 2024 (Values in Cr)
Book Value / Share 1.16
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.09
EBITDA Margin 2.30
Particulars MAR 2023 (Values in Cr)
Book Value / Share 0.55
ROE % 5.63
ROCE % 1.48
Total Debt to Total Equity 0.20
EBITDA Margin 1.41
Particulars MAR 2024 (Values in Cr)
Book Value / Share 1.17
ROE % 0.11
ROCE % 1.81
Total Debt to Total Equity 0.08
EBITDA Margin 2.86
Particulars MAR 2023 (Values in Cr)
Book Value / Share 0.55
ROE % 6.35
ROCE % 1.77
Total Debt to Total Equity 0.10
EBITDA Margin 1.41
Particulars MAR 2022 (Values in Cr)
Book Value / Share 0.56
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -1.57
Particulars MAR 2021 (Values in Cr)
Book Value / Share 0.75
ROE % 6.35
ROCE % 7.61
Total Debt to Total Equity 0.00
EBITDA Margin 7.13
Particulars MAR 2020 (Values in Cr)
Book Value / Share 0.81
ROE % 4.85
ROCE % 5.81
Total Debt to Total Equity 0.00
EBITDA Margin 7.33
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 18.83
Total Assets 71.12
Total Liabilities 71.12
Total Equity 64.53
Share Outstanding 553719700
Price to Book Ratio 1.91
Return on Assets (%) -0.17
Return on Capital (%) -0.19
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.99
Total Assets 19.87
Total Liabilities 19.87
Total Equity 15.33
Share Outstanding 276859850
Price to Book Ratio 5.65
Return on Assets (%) 5.65
Return on Capital (%) 6.11
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 18.57
Total Assets 70.47
Total Liabilities 70.47
Total Equity 64.56
Share Outstanding 553719700
Price to Book Ratio 1.91
Return on Assets (%) 0.06
Return on Capital (%) 0.07
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.99
Total Assets 19.87
Total Liabilities 19.87
Total Equity 15.33
Share Outstanding 276859850
Price to Book Ratio 5.65
Return on Assets (%) 5.65
Return on Capital (%) 6.11
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.60
Total Assets 21.65
Total Liabilities 21.65
Total Equity 15.36
Share Outstanding 276859850
Price to Book Ratio 9.82
Return on Assets (%) -0.96
Return on Capital (%) -1.36
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 3.53
Total Assets 27.81
Total Liabilities 27.81
Total Equity 20.66
Share Outstanding 276859850
Price to Book Ratio 10.68
Return on Assets (%) 4.51
Return on Capital (%) 6.09
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 2.57
Total Assets 24.75
Total Liabilities 24.75
Total Equity 19.03
Share Outstanding 216859850
Price to Book Ratio 15.99
Return on Assets (%) 4.07
Return on Capital (%) 5.3
Particulars MAR 2024 (Values in Cr)
Net Income 0.25
Cash from Operations -2.90
Cash from Investing -28.06
Cash from Financing 47.84
Net change in Cash 16.83
Free Cash Flow -2.88
Particulars MAR 2023 (Values in Cr)
Net Income 0.28
Cash from Operations -3.32
Cash from Investing 0.36
Cash from Financing 3.08
Net change in Cash 0.38
Free Cash Flow -3.30
Particulars MAR 2024 (Values in Cr)
Net Income 0.46
Cash from Operations -2.23
Cash from Investing -29.03
Cash from Financing 47.89
Net change in Cash 16.58
Free Cash Flow -2.21
Particulars MAR 2023 (Values in Cr)
Net Income 0.28
Cash from Operations -3.32
Cash from Investing 0.36
Cash from Financing 3.08
Net change in Cash 0.38
Free Cash Flow -3.30
Particulars MAR 2022 (Values in Cr)
Net Income -0.44
Cash from Operations -2.31
Cash from Investing 0.41
Cash from Financing 0.00
Net change in Cash -1.92
Free Cash Flow -2.23
Particulars MAR 2021 (Values in Cr)
Net Income 1.50
Cash from Operations -1.78
Cash from Investing -1.41
Cash from Financing 4.50
Net change in Cash 0.95
Free Cash Flow -1.77
Particulars MAR 2020 (Values in Cr)
Net Income 1.20
Cash from Operations 1.44
Cash from Investing -4.01
Cash from Financing 0.00
Net change in Cash -2.62
Free Cash Flow 1.49
Company Name Price P/E P/B Market Cap 52 Week Low/High
AEGIS LOGISTICS LIMITED 790.90 48.02 6.73 27760.59 574.70 / 1035.70
KOTHARI INDUSTRIAL CORPORATION 276.45 49.63 18.29 2147.57 3.82 / 276.45
MYSORE PETRO CHEMICALS LTD. 122.85 6.28 0.35 80.88 117.45 / 261.90
OSWAL AGRO MILLS LTD 84.43 22.28 1.34 1133.30 41.50 / 108.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AEGIS LOGISTICS LIMITED 790.90 64.67 11.07 27760.59 574.70 / 1035.70
UTIQUE ENTERPRISES LIMITED 4.66 18.64 0.35 25.94 3.77 / 10.88
COMPUTER POINT LTD. 5.08 0.00 0.45 15.24 4.24 / 11.63
KOTHARI INDUSTRIAL CORPORATION 276.45 49.63 18.31 2147.57 3.82 / 276.45

GENPHARMASEC LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
2.03 -2.40 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 2.10
  • 26 Days 2.10
  • 10 Days 2.10
  • 50 Days 2.20
  • 12 Days 2.10
  • 100 Days 2.40
  • 20 Days 2.10
  • 200 Days 2.60
2.09 PIVOT

First Support

2.04

First Resistance

2.13

Second Support

2.00

Second Resistance

2.18

Third Support

1.95

Third Resistance

2.22

RSI

48.50

ADX

24.56

MACD

0.01

Williams % R

-70.73

Commodity Channel Index (CCI)

24.62

Date

2025-04-29

Week

461523.00

Same Day

266640.00

Month

313490.00

1 Year

0.60

3 Year

0.54

Over 1 Month

9.47%

down

Over 1 Year

-5.88%

down

Over 3 Months

-12.23%

down

Over 3 Years

-15.19%

down

Over 6 Months

-27.27%

down

Over 5 Years

-22.33%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

GENPHARMASEC LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
70.02%
Promoter Holdings
29.97%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Sneha Sadhwani 9.3001E7 (16.8%) Shareholding of Promoter and Promoter Group
Rajesh Sadhwani 7.3E7 (13.18%) Shareholding of Promoter and Promoter Group
Yogeshkumar Rasiklal Sanghavi 3.9148017E7 (7.07%) Public Shareholding
Sadashiv Kanyana Shetty 1.1390991E7 (2.06%) Public Shareholding
Vishesh Mahesh Nihalani 8450100.0 (1.53%) Public Shareholding
Rashmi Nimesh Joshi 7089510.0 (1.28%) Public Shareholding
Anant Wealth Consultants 6950099.0 (1.26%) Public Shareholding
Narendra Chhaganlal Solanki 6009409.0 (1.09%) Public Shareholding

News

Left Arrow
Right Arrow

GENPHARMASEC LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
11 Apr 2019 10.0 1.0 12 Apr 2019

GENPHARMASEC LIMITED Share Price

Genpharmasec Limited was originally incorporated as Public Limited Company on 16th November, 1992 in the State of Gujarat as 'Adi Rasayan Limited'. The Company had received Certificate for Commencement of Business from ROC, Gujarat on November 20, 1992. Further, the name of Company was changed from 'Adi Rayasan Limited' to 'Genpharmasec Limited' on 27th November, 2018. Thereafter, the name of the Company was once again changed from Generic Pharmasec Limited' to ' Genpharmasec Limited' on 25th October, 2021 a fresh Certificate of Incorporation consequent upon the name change was obtained from the Registrar of Companies at Mumbai.

The company implemented a project to manufacture organic and inorganic chemicals, dyes and pigments, at Panoli, Gujarat. Initially, the Company started as a manufacturer and trader of organic and inorganic chemicals, dyes and pigments and from 2018 onwards, ity shifted business activities to buying, selling and distribution of all kinds of pharmaceutical, medicinal and medicated preparations and decided to venture into the securities market. In year 2019, the Company focused to the lucrative medical and diagnostics device segment. The Company tied up with Abbott Point of Care Corporation INC, USA for distribution of their niche diagnostic equipment namely, i-STAT 1 Analyzer which is a hand-held blood analyzer exclusively used in ICUs and ICCUs of hospitals for immediate test results.

Parent organization MNC Associate
NSE symbol [-]
Founded 1992
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Genpharmasec Ltd?

Answer Field

The share price of Genpharmasec Ltd for NSE is ₹ 0.00 and for BSE is ₹ 2.03.

What is the Market Cap of Genpharmasec Ltd?

Answer Field

The market cap of Genpharmasec Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 1,12.40 Cr. as of now.

What is the 52 Week High and Low of Genpharmasec Ltd?

Answer Field

The 52 Week High and Low of Genpharmasec Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 4.32 and ₹ 1.89.

How to Buy Genpharmasec Ltd share?

Answer Field

You can trade in Genpharmasec Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Genpharmasec Ltd?

Answer Field

The 1 year returns on the stock has been -5.88%.

What is the Current Share Price of Genpharmasec Ltd?

Answer Field

Genpharmasec Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 2.03 as on Apr 30 2025 03:29 PM.

What is the Market Cap of Genpharmasec Ltd Share?

Answer Field

The market cap of Genpharmasec Ltd for NSE ₹ 0.0 & for BSE ₹ 1,12.40 as on Apr 30 2025 03:29 PM.

What is the P/E Ratio of Genpharmasec Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM the price-to-earnings (PE) ratio for Genpharmasec Ltd share is 41.60.

What is the PB ratio of Genpharmasec Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM, the price-to-book (PB) ratio for Genpharmasec Ltd share is 1.19.

How to Buy Genpharmasec Ltd Share?

Answer Field

You can trade in Genpharmasec Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Genpharmasec Ltd Share on Bajaj Broking App?

Answer Field

To buy Genpharmasec Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Genpharmasec Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|